Literature DB >> 25616586

Ethics of ambulance diversion.

Joel M Geiderman1, Catherine A Marco2, John C Moskop3, James Adams4, Arthur R Derse5.   

Abstract

Ambulance diversion is a common and controversial method used by emergency departments (EDs) to reduce stress on individual departments and providers and relieve mismatches in the supply and demand for ED beds. Under this strategy, ambulances bound for one hospital are redirected to another, usually under policies established by regional emergency medical services systems. Other responses to this mismatch include maladaptive behaviors (such as "boarding" in "hallway beds") and the development of terminology intended to normalize these practices, all of which are reviewed in this article. We examine the history and causes of diversion as well as the ethical foundations and practical consequences of it. We contend that (1) from a moral viewpoint, the most important stakeholder is the individual patient because diversion decisions are usually relative rather than absolute; (2) decisions regarding ambulance diversion should be made with careful consideration of individual patient preferences, local and state emergency medical services laws, and institutional surge capacity; and (3) authorities should consider the potential positive effects of a regional or statewide ban on diversion.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25616586     DOI: 10.1016/j.ajem.2014.12.002

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

Review 1.  A review on ambulance offload delay literature.

Authors:  Mengyu Li; Peter Vanberkel; Alix J E Carter
Journal:  Health Care Manag Sci       Date:  2018-07-07

2.  Closure simulation for reduction of emergency patient diversion: a discrete agent-based simulation approach to minimizing ambulance diversion.

Authors:  D Pförringer; M Breu; M Crönlein; R Kolisch; K-G Kanz
Journal:  Eur J Med Res       Date:  2018-06-08       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.